acquisition software biosemi activeview (v.605) (BioSemi)
90
Structured Review
BioSemi
acquisition software biosemi activeview (v.605)
Acquisition Software Biosemi Activeview (V.605), supplied by BioSemi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acquisition+software+biosemi+activeview+(v%2E605)/activeview+software/pm40003616-81-7-6
Average 90 stars, based on 1 article reviews
Acquisition Software Biosemi Activeview (V.605), supplied by BioSemi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acquisition+software+biosemi+activeview+(v%2E605)/activeview+software/pm40003616-81-7-6
Average 90 stars, based on 1 article reviews
acquisition software biosemi activeview (v.605) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline. Article Snippet: Early diagnosis and timely treatment of Parkinson’s disease are essential factors to provide these patients with a longer period of a better quality of life.. Olfactory loss is among the first non-motor symptoms of the disease; however, in light of the many causes of smell loss, it is a very unspecific biomarker and should only be used as part of a diagnostic test battery.. In this study, we investigated the olfactory response in 71 subjects, consisting of Parkinson’s disease patients, hyposmic and anosmic patients of other causes, and normosmic individuals searching for sensitive, distinct biomarkers for which we used scalp event-related 64-channel electroencephalography and psychophysical tests. Article Title: The Neural Basis of Salt Perception: A Focus on Potassium Chloride as a Sodium Alternative. Article Snippet: Data were registered and stored using Sampling:Article Title: Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline. Article Snippet: Early diagnosis and timely treatment of Parkinson’s disease are essential factors to provide these patients with a longer period of a better quality of life.. Olfactory loss is among the first non-motor symptoms of the disease; however, in light of the many causes of smell loss, it is a very unspecific biomarker and should only be used as part of a diagnostic test battery.. In this study, we investigated the olfactory response in 71 subjects, consisting of Parkinson’s disease patients, hyposmic and anosmic patients of other causes, and normosmic individuals searching for sensitive, distinct biomarkers for which we used scalp event-related 64-channel electroencephalography and psychophysical tests. Article Title: The Neural Basis of Salt Perception: A Focus on Potassium Chloride as a Sodium Alternative. Article Snippet: Data were registered and stored using |